Rare Disease Day in a COVID-19 environment
February 28, 2021 | Lucid, Medical Communications, Patient journey, charity, rare diseases
For many people and families living with a rare disease, their journey can be very complex. At times, that journey can even be scary, frustrating and confusing. However, when your life is touched by rare disease directly as an individual or as a family or carer, it can often mean entering a new community of dedicated people who ensure that you are not alone and unsupported in that journey. Here we shine a light on just a few key individuals and organisations whose essential support and guidance illuminates the patient journey, provides a network of knowledge and support, and ultimately, improves quality of life.
For many people, the start of the journey doesn’t always begin with a diagnosis: on average, rare disease patients can wait 4 years to receive a diagnosis with some waiting over 20 years(1). With 8 out of 10 rare diseases considered to have a genetic component(2), a key stakeholder to help facilitate an accurate diagnosis is the Clinical Geneticist who can become involved at several different stages:
“(My role can begin…) If a couple are planning on becoming pregnant and there is a rare disease in the family that’s genetic, if we find something on the scan that suggests a genetic problem; or, immediately post-natally with delivery and when a baby is in the special care unit; or, I can be involved when someone is 5 years old and they are having learning difficulties at school and they need to find out why.”
New gene sequencing methods have recently opened doors to earlier diagnosis, though, with the multitude of possible gene mutations, clinical interpretation in terms of diagnosis or severity is not always possible. Evaluation of subtle physical attributes (such as facial features) to aid in clinical diagnosis is an important part of consultations by clinical geneticists. Due to the COVID-19 pandemic, this has been an aspect that has been particularly challenging, as face-to-face consultations to assess the patient are essential. The very sensitive and emotive conversations with parents and families are also difficult in the virtual space, with no additional professional training provided for this new approach. A close relationship between the Clinical Geneticist and Genetic Counsellor helps to provide support for parents to start to make informed choices and life strategies.
“They are professional communicators and have counselling skills as well…If we have a patient who is struggling with a diagnosis, we would involve a genetic counsellor as a counsellor, not just a genetic communicator.”
Clinical Geneticists and Genetic Counsellors are part of the multi-disciplinary team and network of dedicated professionals who ensure continuity of care and treatment for people with rare diseases. Children with rare diseases can often have specialist developmental, behavioural and educational needs. Prior to 1975, children with learning disabilities were dealt with by the health system and did not have the benefit of education. Today, the role of schools, like Park Lane Special School, Macclesfield, Cheshire, is vitally important to provide education as well as life skills such as shopping, cooking and cleaning, which really impacts on quality of life. School Head Teacher, Lorraine Warmer, pointed out that it’s the pupils at Park Lane that make her school so special!
“The children make it such a positive place, what you see is children and young people who are inspiring because they are doing so much to overcome the difficulties they have, but they are doing it in a positive way – there’s lots of smiles, there’s lots of laughter, there’s lots of enthusiasm for learning.”
Children can start at Park Lane from the age of two and stay until the year in which they turn 19. While their education, health and care plan focuses on what the children can’t do, the school explores what they can do and like to do, through a multi-disciplinary team of Teachers, Teaching Assistants and specialists from Speech and Language Therapists, Occupational Therapists, Physiotherapists and Music Therapists.
The school has remained open during the pandemic and technology has been key for children who needed to stay at home for them to access music therapy sessions and share artwork with their classmates. The school’s open-door policy and support through communication boards enables parents to provide the best learning environment for their child and to help parents and families cope with some of the challenges such as specific sensory and behavioural needs.
The school becomes part of the extended family with strong bonds forged between families and teachers, as a child can be at the school for 17 years in total. This makes occasions like the leaver’s assemblies very special indeed – a time when pupils and parents come to terms with the ending of school and a reflection on how much the children have developed and achieved through their lives at Park Lane – before the young adult is guided on the next part of their complex journey, “They deserved to be celebrated.”
Another vital stakeholder in the rare disease community are the specialist charities providing tailored disease-specific guidance and support, for children and their families. Chairman Charles Blockley, of the Cornelia de Lange Syndrome Foundation UK and Ireland, and parent of a child with Cornelia de Lange Syndrome (CdLS), passionately explained that the mission of this charity, run by volunteers, is to ensure early and accurate diagnosis of CdLS, promote research, and enable individuals, families, friends and professionals to make informed decisions and plan for the affected person’s present and future. In CdLS, clinical diagnosis is paramount, as, despite identification of seven mutations, only 70–80% of people have a genetic diagnosis.
“One of the issues with CdLS being so rare is that it’s sometimes very hard to get clinical support within the community. Typically, your GP may have heard of it but probably hasn’t dealt with it before.”
A major achievement of the charity was to orchestrate development and publishing of treatment guidelines in 2018, in the journal, Nature Reviews Genetics(3). The guidelines were cascaded to professionals to aid both identification and diagnosis by clinicians and GPs. Importantly, the charity worked hard with their scientific advisory committee to provide an accessible summary which could be provided to families to facilitate both understanding and communication between patients and healthcare professionals. During the pandemic, the charity has connected with families increasingly through social media and facilitates their interactions with healthcare professionals and other families via their virtual annual conference.
“We held our first virtual congress in October this year, which was very successful…it reached families that sometimes can’t actually travel to the in-person conferences.”
As with all our beacons on this, their mission was not halted by the pandemic, only adapted to the virtual environment. Our beacons have shown that despite the challenges of the pandemic, having a life touched by rare disease does not mean you are alone. Epidemiological facts and figures may describe individuals as one unique person in tens or hundreds of thousands but thanks to the commitment and dedication of a wide range of volunteers and professionals, the rare disease community is stronger than ever.
Download the full article here
References:
1.https://www.raredisease.org.uk/wp-content/uploads/sites/7/2019/02/Illuminating-the-rare-reality-2019.pdf
2.https://www.eurordis.org/sites/default/files/publications/princeps_document-EN.pdf
3.Kline, A.D. et al., Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement. Nat Rev Genet 2018;19:649–666.
https://doi.org/10.1038/s41576-018-0031-0
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data
The winning programme - Treating beyond symptoms in IBD: The Steroid Assessment Tool. Our approach to medical education is really helping to improve patient outcomes and change lives.
Lucid Group shines at the Communiqué Awards
Lucid Group’s commitment to be a leader in medical education was recognised at the Communiqué Awards 2016 in London last night, where the agency received three awards, including being highly...
Developing Medical Education That Advances Patient Outcomes
As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in...
Future-proofing with a comprehensive talent development strategy
Lucid Group is an award-winning group of specialist medical education companies. Over the years, Lucid has developed a strong culture of empowerment, thought-leadership, entrepreneurship and passion to improve outcomes for...
Lucid reach the shortlist for Communiqué 2016 in SIX categories
Lucid Group are celebrating the news that for the first time they have been shortlisted in six different categories at this year’s Communiqué awards. The categories are:Excellence in Communications of...
Lucid Co-founder and COO discusses the changing landscape of healthcare communications
In May’s issue, Jan Steele (Lucid co-founder and COO) talks to PME about the importance of demonstrating value with medical education via validated improvements in patient outcomes. Jan explains that...
New talent blooms at Lucid Group
Spring has most definitely sprung at Lucid Group as they welcome three new employees to their team. Laura Cunliffe joins as a Senior Account Manager at Leading Edge and will...
The art of changing behaviour with virtual technology
In April’s issue of PME, Ella Nuttall (Health Psychology Specialist at Lucid Group) explains how changing behaviour requires a combination of science and art. She outlines how the impact of...
Lucid CEO discusses the importance of company culture
In April’s Smart Thinking blog on pmlive.com, Dennis O’Brien (Lucid CEO) discusses company culture and how individual contribution is everything.Dennis explains that, despite organisations being obsessed with meeting financial targets every...
There’s never a dull moment at Lucid Group
Andrea Hamlin, Angela Tye-Galichet, Emma Herring and Ify Onyeaso were all treated to a fabulous lunch with the Lucid Co-Founders, Dennis O’Brien and Jan Steele in celebration of their 5...